JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB31762

Anti-PCSK9 antibody

0

(1 Review)

|

(29 Publications)

Anti-PCSK9 antibody (ab31762) is a rabbit polyclonal antibody detecting PCSK9 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Mouse, Rat.

- Over 20 publications
- Trusted since 2006

View Alternative Names

Narc1, Pcsk9, Proprotein convertase subtilisin/kexin type 9, Neural apoptosis-regulated convertase 1, Proprotein convertase 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9

4 Images
Western blot - Anti-PCSK9 antibody (AB31762)
  • WB

Project

Western blot - Anti-PCSK9 antibody (AB31762)

ab31762 detects a band of ~62 kDa in liver and kidney lysates from mouse and rat. This corresponds to the cleaved form of PCSK9. ab31762 has not detected the 74 kDa proprotein form in the lysates tested.

All lanes:

Western blot - Anti-PCSK9 antibody (ab31762) at 1 µg/mL

Lane 1:

Liver (Mouse) Tissue Lysate at 10 µg

Lane 2:

Kidney (Mouse) Tissue Lysate at 10 µg

Lane 3:

Liver (Rat) Tissue Lysate at 10 µg

Lane 4:

Kidney (Rat) Whole Cell Lysate - normal tissue (<a href='/en-us/products/unavailable/kidney-rat-whole-cell-lysate-normal-tissue-ab29480'>ab29480</a>) at 10 µg

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

Predicted band size: 74 kDa

Observed band size: 62 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-PCSK9 antibody (AB31762)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PCSK9 antibody (AB31762)

ICC/IF image of ab31762 stained PC12 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab31762 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PCSK9 antibody (AB31762)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PCSK9 antibody (AB31762)

IHC image of ab31762 staining in mouse large intestine formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol B. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab31762, 5µg/ml, for 15 mins at room temperature. A goat anti-rabbit biotinylated secondary antibody was used to detect the primary, and visualized using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunoprecipitation - Anti-PCSK9 antibody (AB31762)
  • IP

Unknown

Immunoprecipitation - Anti-PCSK9 antibody (AB31762)

PCSK9 was immunoprecipitated using 0.5mg Mouse Liver tissue, 5μg of Rabbit polyclonal to PCSK9 and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).

The antibody was incubated under agitation with Protein G beads for 10min, Mouse Liver tissue lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.

Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70°C; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab31762.

Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).

Band : 62kDa; PCSK9

All lanes:

Immunoprecipitation - Anti-PCSK9 antibody (ab31762)

Predicted band size: 74 kDa

true

Exposure time: 20min

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat

Applications

IHC-P, IP, ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

From Jan 2024, QC testing of replenishment batches of this polyclonal changed. All tested and expected application and reactive species combinations are still covered by our Abcam product promise. However, we no longer test all applications. For more information on a specific batch, please contact our Scientific Support who will be happy to help.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-PCSK9 antibody (ab31762) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse, Rat samples.

What is the molecular weight of PCSK9?
Anti-PCSK9 (ab31762) specifically detects a band for PCSK9 (UniProt: Q8NBP7) at a molecular weight of 74kDa.

Trusted by the scientific community
Anti-PCSK9 (ab31762) was first used in a scientific publication in 2006 and has been cited over 20 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protein responsible for the regulation of cholesterol levels by binding to low-density lipoprotein receptors (LDLR) on hepatocytes. This interaction marks the LDLRs for degradation reducing the liver's ability to clear LDL cholesterol from the blood. PCSK9 has a molecular weight of approximately 74 kDa. The protein is mainly expressed in the liver but is also found in the intestine and kidneys. PCSK9 is referred to as NARC-1 standing for neural apoptosis-regulated convertase 1 highlighting its role in the liver's cholesterol management system.
Biological function summary

PCSK9 influences cholesterol homeostasis by its important role in degrading LDL receptors. It functions independently rather than as part of larger protein complexes. PCSK9 gains particular interest in therapeutic contexts where its inhibition can lead to increased LDLR levels and enhanced clearance of LDL cholesterol. Biotinylated PCSK9 and mouse PCSK9 variants provide significant tools for experimental study. Kits such as the PCSK9 ELISA kit enable detailed measurement of PCSK9 levels in blood samples providing insights into cholesterol metabolism dynamics.

Pathways

PCSK9 operates within the lipid metabolism pathway and the cholesterol biosynthesis pathway. The protein's activity affects the fate of LDL cholesterol within these pathways. It interacts with proteins such as apolipoprotein B (ApoB) which plays a central role in the structural component of LDL particles. The modulation of these pathways by PCSK9 highlights the significance of its function in maintaining cardiovascular health and managing cholesterol levels.

PCSK9 is closely linked to hypercholesterolemia and coronary artery disease. Mutations in PCSK9 can lead to autosomal dominant hypercholesterolemia due to its effect on LDL receptor degradation. Other proteins such as ApoB and LDLR are involved in these conditions tightly interacting with PCSK9's regulatory function. A better understanding of PCSK9's role offers potential therapeutic targets for cardiovascular disease interventions especially through the development of PCSK9 antibodies and PCSK9 assays that adjust cholesterol levels.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members : low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.
See full target information Pcsk9

Publications (29)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:22067 PubMed40593844

2025

The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Shuai Shi,Zhihui Qin,Chang Liu,Yanru Zhao,Xiaopeng Bai,Chaoyu Sun,Xu Li,Wanting Cong,Xinyue Yuan,Lixiu Sun,Bingchen Liu,Xueqi Li

Endokrynologia Polska 76:116-123 PubMed40071808

2025

PCSK9/LOX-1 is associated with T2DM and regulates high glucose-induced lipid metabolism dysfunction in human microvascular endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Yao,Hong Liu

Biochemical and biophysical research communications 742:151081 PubMed39632291

2024

PCSK9 promotes vascular neointimal hyperplasia through non-lipid regulation of vascular smooth muscle cell proliferation, migration, and autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Zhang,Mengdan Miao,Shanhu Cao,Da Liu,Zelong Cao,Xiaoyu Bai,Yajuan Yin,Sheng Jin,Lihua Dong,Mingqi Zheng

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23127 PubMed37561547

2023

PCSK9 causes inflammation and cGAS/STING pathway activation in diabetic nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Zhicai Feng,Xiangyu Liao,Juan Peng,Jingjing Quan,Hao Zhang,Zhijun Huang,Bin Yi

Inflammation 46:2102-2119 PubMed37466835

2023

Anti-PCSK9 Treatment Attenuates Liver Fibrosis via Inhibiting Hypoxia-Induced Autophagy in Hepatocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Liuxin Ning,Yanting Zou,Shuyu Li,Yue Cao,Beili Xu,Shuncai Zhang,Yu Cai

Renal failure 45:2215880 PubMed37246753

2023

Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus.

Applications

Unspecified application

Species

Unspecified reactive species

Zhicai Feng,Xiangyu Liao,Hao Zhang,Juan Peng,Zhijun Huang,Bin Yi

Theranostics 13:2914-2929 PubMed37284459

2023

PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging.

Applications

Unspecified application

Species

Unspecified reactive species

Shijie Liu,Jinzi Wu,Amanda Stolarz,Huiliang Zhang,Marjan Boerma,Stephanie D Byrum,Nancy J Rusch,Zufeng Ding

Journal of biochemical and molecular toxicology 37:e23346 PubMed36988443

2023

Dendritic cell-derived exosomal miR-3064-5p inhibits SIRT6/PCSK9 to protect the blood-brain barrier after subarachnoid hemorrhage.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Wang,Long Zhang,Li Lv,Ziqi Zhou,Haipeng Xi

Antioxidants (Basel, Switzerland) 12: PubMed36830035

2023

Di-(2-ethylhexyl) Phthalate Limits the Lipid-Lowering Effects of Simvastatin by Promoting Protein Degradation of Low-Density Lipoprotein Receptor: Role of PPARγ-PCSK9 and LXRα-IDOL Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Bei-Chia Guo,Ko-Lin Kuo,Jenq-Wen Huang,Chia-Hui Chen,Der-Cherng Tarng,Tzong-Shyuan Lee

Cardiovascular toxicology 22:951-961 PubMed36342620

2022

PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Guangwei Huang,Xiyang Lu,Zonggang Duan,Kai Zhang,Lei Xu,Hailong Bao,Xinlin Xiong,Muzhi Lin,Chao Li,Yunquan Li,Haiyan Zhou,Zhenhua Luo,Wei Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com